Search for: "Mylan Pharmaceuticals" Results 141 - 160 of 738
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Mylan Pharmaceuticals, Inc., the Federal Circuit reversed the District Court of New Jersey’s grant of summary judgement in favor of Valeant that claim 8 of U.S. [read post]
20 Oct 2009, 1:15 am
The US Attorney’s office in New Hampshire announced yesterday the settlement of a qui tam alleging that four pharmaceutical companies - Mylan Pharmaceuticals, UDL Laboratories, Aztra-Zeneca Pharmaceuticals, and Ortho-McNeill - mischaracterized their prescription drugs to state Medicaid programs. [read post]
23 Mar 2009, 2:21 pm
Reddy's Laboratories, and Cobalt Pharmaceuticals. '639 claims an anti-epileptic drug that UCB markets as Keppra. [read post]
25 Aug 2011, 5:58 am by Medicare Set Aside Services
A generic version of Amrix® (cyclobenzaprine extended-release) was released by Mylan pharmaceuticals on 05/13/2011. [read post]
11 Sep 2012, 5:30 am by Gene Quinn
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
3 May 2011, 7:16 am by Zoe Tillman
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
22 Oct 2009, 6:55 am by admin
On October 19, 2009, the Department of Justice announced that four pharmaceutical manufacturers, Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals, and Ortho McNeil Pharmaceutical settled claims brought against them under the False Claims Act for $124 million. [read post]
21 May 2012, 9:33 pm by Patent Docs
Mylan Pharmaceuticals Inc. 1:12-cv-00523; filed April 26, 2012 in the District Court of Delaware Infringement of U.S. [read post]
1 Aug 2009, 8:57 am
Pharmaceutical companies occasionally submit data to the FDA they know is false. [read post]
15 Sep 2013, 9:42 pm by Patent Docs
• Defendant: Mylan Pharmaceuticals Inc. [read post]
21 Aug 2018, 9:58 pm by Patent Docs
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
6 Mar 2017, 9:00 am by Brianna Smith
From Mylan and their Epipen fiasco to Teva Pharmaceutical Industries Ltd, consumers are wondering when someone will step in to make this price gouging stop before drugs like the Epipen simply become unaffordable. [read post]
6 Feb 2019, 5:15 pm by Scott McKeown
Statutory Right to Appeal for Joined Parties In Mylan Pharmaceuticals Inc. v. [read post]
27 Jan 2010, 9:04 pm by Patent Docs
District Court for the District of Delaware has ruled that Bristol-Myers Squibb may proceed with its patent infringement suit against defendants Mylan Pharmaceuticals and Matrix Laboratories over Bristol-Myers' patent covering the HIV treatment Sustiva®, U.S. [read post]
19 Dec 2018, 11:46 am by Slappey & Sadd, LLC
Earlier this month, Mylan Pharmaceuticals announced a recall of three blood pressure medications that were found to contain small amounts of a substance believed to cause cancer. [read post]
15 Feb 2007, 8:26 am
The '006 patent covers the drug topiramate, pharmaceutical compositions containing topiramate, and a method of using topiramate to treat convulsions. [read post]
15 May 2011, 9:07 pm by Aaron Barkoff
UPDATE:  On May 16, Watson Pharmaceuticals announced that it launched an authorized generic version of Amrix, supplied by Cephalon's Anesta AG subsidiary. [read post]